Alzheimer disease risk and genetic variation in ACE: a meta-analysis

Neurology. 2004 Feb 10;62(3):363-8. doi: 10.1212/01.wnl.0000106823.72493.ff.

Abstract

Background: Numerous studies have tested for associations between common variants of the angiotensin-converting enzyme gene (ACE) and late-onset Alzheimer disease (AD), but results have been inconclusive.

Methods: Relevant studies were systematically identified, and data were abstracted according to predefined criteria.

Results: The odds ratio (OR) for AD in individuals with the I allele of the ACE D/I polymorphism compared with those with the DD genotype was 1.27 (95% CI, 1.10 to 1.47; p < 0.001). Heterogeneity between studies was significant (p < 0.001) but not in strata defined by race and age (p > or = 0.10). The risk of AD associated with the I allele appeared to be higher among Asians (OR 2.44; 95% CI, 1.68 to 3.53) when compared with the risk among Caucasians (OR 1.18; 95% CI, 1.02 to 1.37) (p for comparison < 0.001), and in younger cases (mean age 65 to 74 years) (OR 1.54; 95% CI, 1.23 to 1.93) when compared with the risk in older cases (OR 1.13; 95% CI, 0.95 to 1.35) (p for comparison = 0.03).

Conclusions: The I allele of the ACE D/I polymorphism is associated with an increased risk of late-onset AD. Further study of the pathogenetic characteristics of this allele and independent confirmation of the association in larger studies are warranted.

Publication types

  • Meta-Analysis

MeSH terms

  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics
  • Asian People / genetics
  • Genetic Heterogeneity
  • Genetic Predisposition to Disease
  • Genetic Variation*
  • Genotype
  • Humans
  • Linkage Disequilibrium
  • Middle Aged
  • Mutagenesis, Insertional
  • Odds Ratio
  • Peptidyl-Dipeptidase A / genetics*
  • Risk
  • White People / genetics

Substances

  • Peptidyl-Dipeptidase A